Breaking News

Crown Bioscience Expands Capabilities

Names Pang as new scientific director

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Crown Bioscience has entered an exclusive preclinical services alliance for the largest collection of naturally occurring diabetic translational models. The models are designed for research involving cardiovascular and metabolic diseases, including spontaneous developed diabetes and its complications. They were developed to mirror aspects of human disease related to obesity, nephropathy, hyperglycemia, hyperinsulinemia, dyslipidemia, glucose intolerance, reduced glucose disposition, insulin resi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters